glp 1 agonists and inflammation Frontiers Frontiers | GLP-1 receptor agonists
Description
10.1016/j.diabres.2014.04.006 24
9-11 It should be noted that there are several well-designed landmark trials investigating a GLP-1 RA in addition to basal insulin with placebo or other comparators
But some researchers titrate too slowly, sitting at sub-therapeutic doses for months
Potential sleep disturbances and bone pain in some individuals
They are also administered at different doses and last for different durations
